TrialSTOP-HAE: A Phase 3 Study of ADX-324 in HAE
Trial details
- Registry ID
- NCT06960213
- Phase
- Phase 3
Drug research
ADX-324
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as siRNA
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| STOP-HAE: A Phase 3 Study of ADX-324 in HAENCT06960213 | ADARx Pharmaceuticals, Inc. | Phase 3 | Recruiting | 2027-11-30Estimated |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |